Infectious Diseases Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety Study of SLV213 for the Treatment of COVID-19.
Conditions: COVID-19 Interventions: Other: Placebo for SLV213; Drug: SLV213 Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

Role of CBC Parameters in Early Diagnosis of Pediatric Pneumonia
Conditions: Pediatric Infectious Disease Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

FDA Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia Associated with Viral Infection
TAIPEI, Nov. 21, 2023. Senhwa Biosciences, Inc., a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. Food and Drug Administration has approved its Phase... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 22, 2023 Category: Pharmaceuticals Source Type: clinical trials

Feasibility and Effectiveness of a Pilot Program of Physical Activity to Improve HIV Related Functional Limitations and Disability in Adults Aged 40 and Older From C ôte d'Ivoire
Conditions: HIV Infections Interventions: Procedure: Quantitative research; Behavioral: Qualitative survey Sponsors: ANRS, Emerging Infectious Diseases; Centre Population et D éveloppement (CEPED/IRD); Programme PAC-CI Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Protocol CAUSE-03 / CHEETAH
Conditions: Asthma Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Conditions: Mpox Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; National Institute of Allergy and Infectious Diseases (NIAID); Leidos Biomedical Research, Inc.; Alliance for International Medical Action; University of California, Los Angeles; Institut de Recherche pour le Developpement; University of Manito ba Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
Conditions: HIV Infections; Aging Interventions: Other: biopsy Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial
ConclusionsIn conclusion, the combination of BCc1 and Hep-S inhibits IL-6 as a highly important and well-known cytokine in COVID-19 pathophysiology and presents a promising view for immunomodulation that can manage CSS.Trial registrationIranian Registry of Clinical TrialsRCT20170731035423N2. Registered on June 12, 2020. (Source: Trials)
Source: Trials - November 11, 2023 Category: Research Source Type: clinical trials

Enhancing open clinical trials through blinded evaluations: an exploration with diabetic foot infections
ConclusionsThe study highlighted that evaluations from non-blinded site investigators may potentially exaggerate the efficacy of the experimental group and that deep wounds can present challenges for observation via center-reading photos. These findings underline the vital necessity for objective assessment in open clinical trials, especially those where wound observation serves as the primary efficacy indicator. The study suggests the adoption of independent blinded investigators at each site, complemented by a comprehensive set of standard operating procedures for blinding evaluation. These measures could serve as an eff...
Source: Trials - November 9, 2023 Category: Research Source Type: clinical trials

Spatial Repellents for Malaria Control
Conditions: Malaria Interventions: Device: Transfluthrin Sponsors: University of Notre Dame; SC Johnson, A Family Company; Catholic Relief Services; Infectious Diseases Research Collaboration, Uganda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials

Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Conditions: Healthy Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
Conditions: Congenital Cytomegalovirus Infection Interventions: Drug: Letermovir Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials

Mechanistic Insights From Bronchoscopy Airway Samples
Conditions: Asthma Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN-103)
Conditions: Pre-Exposure Prophylaxis of HIV Infection Interventions: Drug: Lenacapavir Injection; Drug: Lenacapavir Tablet; Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF) Sponsors: Gilead Sciences; HIV Prevention Trials Network; National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Genetic Susceptibility to Severe Infections
Conditions: Infectious Disease Interventions: Other: Blood samples drawing; Other: Skin biopsy Sponsors: Institut National de la Sant é Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials